GENEVA, Switzerland, December 19 /PRNewswire/ -- Merck KGaA announced today that it has entered into a worldwide licensing and collaboration agreement on behalf of its Merck Serono division with…

MELBOURNE, Australia, December 19 /PRNewswire/ -- Cancer Therapeutics CRC Pty Ltd and the Queensland Institute of Medical Research (QIMR) today announced a collaboration to discover and develop new…

A genetic mutation expands lesions in the aorta and promotes coronary atherosclerosis, more commonly known as hardening of the arteries, according to a study by Yale School of Medicine in Cell…

AMSTERDAM, Netherlands, December 17 /PRNewswire/ -- - Agendia to file for expanded FDA clearance for MammaPrint(R) Agendia BV, world leader in the rapidly evolving field of molecular diagnostics,…

PLANEGG-MARTINSRIED, Germany, December 17 /PRNewswire/ -- The Management Board and the Supervisory Board of the drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC), with…

OXFORD, England, December 17 /PRNewswire/ -- - New Deal Provides a Further Opportunity for OGeS to Grow its Therapeutic Antibody Pipeline Oxford Genome Sciences (UK) Ltd "OGeS" announces today that…

Researchers of the Institute of Molecular Biology, Russian Academy of Sciences, have been working for more than 20 years on designing biological microchips for efficient and quick diagnostics of…

LONDON, December 14 /PRNewswire/ -- - The Benefits of Anastrozole (Arimidex(R)) Over Tamoxifen at Preventing Breast Cancer Recurrence Improve Over Time - Up to Four Years After Treatment Ends New…

Natural selection can occur at the cellular level, where it is detrimental to health. Fortunately it is normally controlled by a well-known pattern of ongoing cell differentiation in the mature…

Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children’s Hospital Boston, Dana-Farber Cancer Institute (…